← Back to Search
Nanoparticle-based Strategies For Cancer Immunotherapy And Immunodiagnostics.
A. Grimaldi, M. Incoronato, M. Salvatore, A. Soricelli
Published 2017 · Medicine, Materials Science
Download PDFAnalyze on Scholarcy
Although recent successes in clinical trials are strengthening research focused on cancer immunology, the poor immunogenicity and off-target side effects of immunotherapeutics remain major challenges in translating these promising approaches to clinically feasible therapies in the treatment of a large range of tumors. Nanotechnology offers target-based approaches, which have shown significant improvements in the rapidly advancing field of cancer immunotherapy. Here, we first discuss the chemical and physical features of nanoparticulate systems that can be tuned to address the anticancer immune response, and then review recent, key examples of the exploited strategies, ranging from nanovaccines to NPs revising the tumor immunosuppressive microenvironment, up to immunotherapeutic multimodal NPs. Finally, the paper concludes by identifying the promising and outstanding challenges the field of emerging nanotechnologies is facing for cancer immunotherapy.
This paper references
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.
Jineun Park (2012)
Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells.
Y. Lim (2008)
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
J. Brahmer (2012)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L. Thiele (2001)
Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner.
Y. Xu (2015)
Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.
Zhanguo Yue (2011)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp (2009)
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
I. Kourtis (2013)
Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models.
Rachit Agarwal (2015)
Macrophage uptake of Janus particles depends upon Janus balance.
Yuan Gao (2015)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
M. Dobrovolskaia (2008)
The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells.
Ángeles Villanueva (2009)
Biomaterials for enhancing anti-cancer immunity.
Sandeep T. Koshy (2016)
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Y. Zhuang (2012)
Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo.
I. Lee (2012)
Tumor‐targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
Meirong Huo (2017)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
Nanoparticulate immunotherapy for cancer.
Chintan H. Kapadia (2015)
Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ane Ruiz-de-Angulo (2016)
Impact of particle elasticity on particle‐based drug delivery systems☆
Aaron C. Anselmo (2017)
Composition and Surface Charge of DNA-Loaded Microparticles Determine Maturation and Cytokine Secretion in Human Dendritic Cells
S. Jilek (2004)
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
M. C. Popescu (2007)
Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Y. Yoshizaki (2014)
The effects of particle size, density and shape on margination of nanoparticles in microcirculation.
R. Toy (2011)
The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows.
F. Gentile (2008)
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging.
R. Meir (2015)
How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells.
L. Florez (2012)
Therapeutic cell engineering using surface-conjugated synthetic nanoparticles
M. Stephan (2010)
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
O. Hamid (2013)
Differential functional effects of biomaterials on dendritic cell maturation.
J. Park (2012)
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route
W. Ge (2008)
Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H. Shen (2006)
Stable cationic microparticles for enhanced model antigen delivery to dendritic cells.
C. Wischke (2006)
The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses.
Yifan Ma (2011)
Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
J. Kim (2015)
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
P. Kantoff (2010)
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy.
N. Cho (2011)
Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy
A. Lin (2013)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
S. T. Reddy (2006)
Magnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivo.
Y. Chen (2014)
Multimodal imaging of dendritic cells using a novel hybrid magneto-optical nanoprobe.
Patrick S Mackay (2011)
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
C. Oussoren (1997)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice
Dean Johnston (2005)
Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters.
K. Cohen (2014)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
S. T. Reddy (2007)
A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
F. Duan (2017)
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Stacey L. Demento (2009)
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.
M. Kortylewski (2009)
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
D. Getts (2014)
Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production1
Carla A Da Silva (2009)
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.
Zhiping Zhang (2011)
Particle-mediated delivery of cytokines for immunotherapy.
D. Christian (2012)
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
Eva Schlosser (2008)
Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016).
Daniel R. Getts (2016)
Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging
Karen C. Briley‐Saebo (2010)
Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
Armando Stano (2013)
Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).
James I Andorko (2017)
Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.
B. Sun (2013)
Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model.
D. Liao (2011)
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
Comparison of PLA Microparticles and Alum as Adjuvants for H5N1 Influenza Split Vaccine: Adjuvanticity Evaluation and Preliminary Action Mode Analysis
W. Zhang (2013)
ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES
J. Szebeni (2002)
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
B. Li (2016)
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
Zoe N Hunter (2014)
Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
F. Shima (2013)
The Toxicology of Interleukin-12: A Review
B. Car (1999)
Pathogen recognition and development of particulate vaccines: does size matter?
S. Xiang (2006)
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes.
W. Ge (2009)
Cancer immunotherapy comes of age
I. Mellman (2011)
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.
Stacey L. Demento (2012)
Particle shape enhances specificity of antibody-displaying nanoparticles
Sutapa Barua (2013)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
R. Fang (2014)
Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy.
Z. Huang (2012)
Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response.
Young-Woock Noh (2011)
Particle Margination and Its Implications on Intravenous Anticancer Drug Delivery
Erik J Carboni (2014)
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan (2015)
Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles.
M. Wei (2012)
Cytokines in Cancer Immunotherapy
S. Lee (2011)
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1
Karen Zaks (2006)
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.
Y. Zhao (2015)
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
M. Oyewumi (2010)
Reporter nanoparticle that monitors its anticancer efficacy in real time
A. Kulkarni (2016)
Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production
S. Moein Moghimi (2006)
Multifunctional nanoparticle developments in cancer diagnosis and treatment
S. Parvanian (2017)
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu (2014)
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
S. Fischer (2007)
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
D. Mohanan (2010)
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Zhenghong Xu (2013)
Design opportunities for actively targeted nanoparticle vaccines.
T. Fahmy (2008)
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting.
Aaron C. Anselmo (2015)
Antigen kinetics determines immune reactivity
P. Johansen (2008)
Role of target geometry in phagocytosis.
J. Champion (2006)
Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.
Nijaporn Yanasarn (2011)
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Heleen Dewitte (2014)
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
Lázaro Moreira Marques Neto (2017)
Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.
Songwei Tan (2014)
Shape and size-dependent immune response to antigen-carrying nanoparticles.
S. Kumar (2015)
Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI.
Sonali N de Chickera (2011)
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
Shoshy Mizrahy (2014)
Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1
T. Uto (2007)
Targeting the lymphatics using dendritic polymers (dendrimers).
L. M. Kaminskas (2011)
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
L. Jeanbart (2015)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
S. T. Reddy (2006)
Nivolumab plus ipilimumab in the treatment of advanced melanoma
K. Tsai (2015)
Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.
S. Mueller (2015)
Biodistribution and tumor localization of stealth liposomal tumor necrosis factor‐α in soft tissue sarcoma bearing rats
Alexander H. van der Veen (1998)
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
João Conniot (2014)
Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages
L. Thiele (2004)
Polysaccharides as building blocks for nanotherapeutics.
Shoshy Mizrahy (2012)
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory.
C. Wang (2015)
Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
L. Cruz (2011)
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1
T. Fifis (2004)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.
C. Foged (2005)
Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice.
T. Fifis (2004)
Nanoparticles target distinct dendritic cell populations according to their size
V. Manolova (2008)
This paper is referenced by
Tissue-Engineered Vascular Grafts: Recellularisation and Surface Functionalisation with Hybrid Magnetic Nanomedicine Developed with Theranostic Potential
Tatiane Eufrásio da Silva (2018)
Nanoparticles for dendritic cell-based immunotherapy.
T. H. Tran (2018)
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
Marina A Dobrovolskaia (2019)
Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level
A. Kostopoulou (2018)
Nanoparticle-based immunotherapy: state of the art and future perspectives
M. Di Gioacchino (2020)
Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
A. Kermanizadeh (2018)
Pristine large pore benzene-bridged mesoporous organosilica nanoparticles as an adjuvant and co-delivery platform for eliciting potent antitumor immunity
Manasi Jambhrunkar (2020)
Nanoparticles: Properties and Applications in Cancer Immunotherapy.
Alessandra Iscaro (2019)
Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy.
Wenjun Wang (2019)
Recent Advances in Particulate Adjuvants for Cancer Vaccination
Cui Song (2020)
Novel treatment strategies in cancer immunotherapy
H. Yoon (2018)
Engineering nanoparticle strategies for effective cancer immunotherapy.
H. Yoon (2018)
Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
B. Zheng (2018)
Electron microscopy in human diseases: diagnostic and research perspectives.
Manuel Scimeca (2019)
Nanotechnology Approaches to Improving Cancer Immunotherapy.
C. Hagan (2018)
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
Mouldy Sioud (2019)
Influenza mimetic protein-polymer nanoparticles as antigen delivery vehicles to dendritic cells for cancer immunotherapy.
Chaeyeon Lee (2019)
Multifunctional and Stimuli‐Responsive Magnetic Nanoparticle‐Based Delivery Systems for Biomedical Applications
H. Y. Yang (2018)
Jacopo Sforzi (2020)
Biofunctional iron oxide nanoparticles as vaccine adjuvants for enhanced anti-cancer immunotherapy
Bocanegra Gondan (2017)
Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?
Purushottam Lamichhane (2018)